Seattle Genetics Backtesting

Seattle Genetics Inc -- USA Stock  

USD 55.27  3.99  6.73%

With this equity back-testing module your can estimate the performance of a buy and hold strategy of Seattle Genetics Inc and determine expected loss or profit from investing in Seattle Genetics over given investment horizon. Also please take a look at Seattle Genetics Hype Analysis, Seattle Genetics Correlation, Seattle Genetics Valuation, Seattle Genetics Volatility as well as analyze Seattle Genetics Alpha and Beta and Seattle Genetics Performance
Investment Horizon     30 Days    Login   to change

Seattle Genetics 'What if' Analysis

November 11, 2017
No Change 0.00  0.0%
In 31 days
December 11, 2017
If you would invest  0.00  in Seattle Genetics on November 11, 2017 and sell it all today you would earn a total of 0.00 from holding Seattle Genetics Inc or generate 0.0% return on investment in Seattle Genetics over 30 days. Seattle Genetics is related to or competes with Vertex Pharmaceuticals, Endo International, Abbott Laboratories, Allergan plc, and Bio Rad. It markets ADCETRIS an antibodydrug conjugate for the treatment of relapsed Hodgkin lymphoma and relapsed systemic anapl...

Seattle Genetics Upside/Downside Indicators


Seattle Genetics Market Premium Indicators

Seattle Genetics Inc lagged returns against current returns

 Current and Lagged Values 

Seattle Genetics regressed lagged prices vs. current prices

 Current vs Lagged Prices 

Seattle Genetics Inc Backtested Returns

Macroaxis considers Seattle Genetics to be not too volatile. Seattle Genetics Inc owns Efficiency Ratio (i.e. Sharpe Ratio) of -0.0405 which indicates Seattle Genetics Inc had -0.0405% of return per unit of risk over the last 1 month. Macroaxis philosophy towards measuring risk of any stock is to look at both systematic and un-systematic factors of the business, including all available market data and technical indicators. Seattle Genetics Inc exposes twenty-one different technical indicators which can help you to evaluate volatility that cannot be diversified away. Please be advised to validate Seattle Genetics Coefficient Of Variation of (1,209) and Risk Adjusted Performance of (0.033294) to confirm risk estimate we provide. Macroaxis gives Seattle Genetics performance score of 0 on a scale of 0 to 100. The entity has beta of 1.5228 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Seattle Genetics will likely underperform.. Even though it is essential to pay attention to Seattle Genetics Inc current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Seattle Genetics Inc exposes twenty-one different technical indicators which can help you to evaluate its performance. Seattle Genetics Inc has expected return of -0.0903%. Please be advised to validate Seattle Genetics Variance as well as the relationship between Value At Risk and Skewness to decide if Seattle Genetics Inc past performance will be repeated at some point in the near future.
Advice Volatility Trend Exposure Correlations
15 days auto-correlation(0.07) 

Very weak reverse predictability

Seattle Genetics Inc has very weak reverse predictability. Overlapping area represents the amount of predictability between Seattle Genetics time series from November 11, 2017 to November 26, 2017 and November 26, 2017 to December 11, 2017. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Seattle Genetics Inc price movement. The serial correlation of -0.07 indicates that barely 7.0% of current Seattle Genetics price fluctuation can be explain by its past prices. Given that Seattle Genetics Inc has negative autocorrelation for selected time horizon, investors may consider taking a contrarian position regarding future price movement of Seattle Genetics for similar time interval.
Correlation Coefficient -0.07
Spearman Rank Test -0.33
Price Variance 1.87
Lagged Price Variance 0.76

Seattle Genetics Lagged Returns

 Regressed Prices 

Seattle Genetics Performance vs DOW

The median price of Seattle Genetics for the period between Sat, Nov 11, 2017 and Mon, Dec 11, 2017 is 58.69 with a coefficient of variation of 2.26. The daily time series for the period is distributed with a sample standard deviation of 1.32, arithmetic mean of 58.27, and mean deviation of 1.07. The Stock received some media coverage during the period.
Price Growth (%)  
Seattle Genetics and Takeda Highlight Positive Data from Pha...12/11/2017